Blood Banking and Transfusion Medicine Challenges During the COVID-19 Pandemic

Area of Science:

• Hematology and Transfusion Medicine
• Infectious Diseases
• Public Health

Background:

• The emergence of SARS-CoV-2 (COVID-19) presented significant challenges to healthcare systems globally.
• Blood banking operations and patient blood management faced unprecedented disruptions due to the pandemic.
• A decline in blood supply and the need for donor safety protocols became critical issues.

Purpose of the Study:

• To analyze the impact of COVID-19 on national blood collection and blood banking operations.
• To review the new policies implemented in response to decreased blood supply and donor protection.
• To discuss the development of policies for convalescent plasma therapy.

Main Methods:

• Review of national blood collection data and blood bank operational changes.
• Analysis of newly adopted patient blood management strategies.
• Examination of emerging policies for convalescent plasma utilization.

Main Results:

• COVID-19 significantly decreased nationwide blood collection rates.
• New policies were implemented by blood banks, centers, and government bodies to address supply shortages and ensure donor safety.
• Challenges remain in establishing clear efficacy and safety profiles for convalescent plasma therapy.

Conclusions:

• The COVID-19 pandemic necessitated significant adaptations in blood banking and patient blood management.
• Continued research and policy development are crucial for managing blood supply and novel therapies like convalescent plasma.
• The long-term implications of these changes on blood transfusion services require ongoing evaluation.